UIC Pharmacy masthead

Office of the Dean

National Advisory Board

The National Advisory Board serves as a wealth of knowledge for Dean Bauman and the college as a whole. For more information on the board or to learn how you may become a member, please contact our Director of Advancement, Chris Shoemaker, at (312) 996-3376 or cjshoema@uic.edu

Sharon Ayd

Sharon W. Ayd, PhD ‘97, MBA
Global Vice President, Innovation and Development – Fresenius Kabi USA

Sharon W. Ayd, Ph.D., MBA, was previously with One 2 One and had been with Hospira since 2004. One 2 One leverages Hospira technology to manufacture product for third parties and is one of the most profitable parts of Hospira. With scientific teams located in North America, Europe and APAC, Sharon’s organization provides R&D support and services to customers located around the world. Sharon has significant scientific and business experience from having worked in drug discovery, Pharma, biopharmaceutical and generic drug development. Prior to joining Hospira, she was Chief Operating Officer at Advanced Life Sciences, a start up Biopharmaceutical Company. Prior to joining Advanced Life Sciences, she was Director, R&D at Apotex Corporation, Canada’s largest generic drug corporation. Sharon was also a founding employee and member of senior management at Transcend Therapeutics, a Cambridge-based biopharmaceutical company spun off from Baxter International. Sharon is a published author, invited speaker, Adjunct Professor to the University of Illinois at Chicago’s College of Pharmacy (UIC COP), an active member of the UIC COP National Advisory Board and a recipient of numerous academic and professional honors and awards.

Mark Bachleda

Mark Bachleda, PharmD, '99, MBA
Executive Director, Oncology Sales – SE Region, Amgen

Mark has over 12 years of experience in the biopharmaceutical industry across Sales Management, Marketing, Pricing & Market Access, and Medical Affairs.  He has been with AMGEN, Inc since 2003 in sales and marketing roles of increasing responsibility on the Aranesp® & EPOGEN® brand teams and Nephrology Sales Management.  Currently, Mark is part of the International Commercial management team located in Thousand Oaks, CA as the Director, Strategy & Operations reporting to the Senior Vice President, International Commercial Operations.  His responsibilities include supporting AMGEN's interests in Asia/Japan, the commercialization process, and business development.  He also partners with their International HQ based in Zug, Switzerland to ensure tight coordination with the operational aspects of the commercial business. 

Prior to AMGEN, Mark worked for PFIZER, Inc in Pricing & Market Access (US & ex-US) and JOHNSON & JOHNSON in Medical Affairs.  He is a registered pharmacist and received his Doctor of Pharmacy degree from the University of Illinois at Chicago (PharmD '99).  Mark completed a Post-Doctoral Fellowship in Health Policy & Economics at Thomas Jefferson University in Philadelphia, PA and holds Master of Business Administration (MBA) degrees from Columbia University and University of California, Berkeley. 

Mark's wife is also a graduate from UIC, Joy Ellen Zarlenga, PharmD ('02), MPH ('03) and they have three children. 

Francesca Cunningham

Francesca Cunningham, PharmD '02 RES
Director of the Center for Medication Safety (NCPS)
Program Director of Outcomes Assessment at the Department of Veteran Affairs (VA)
Pharmacy Benefits Management Services (PBM)

Dr. Cunningham was the driving force behind the successful effort of PBM to establish reliable methods for merging the VA prescription database with other large VA-related databases in order to evaluate the safe and appropriate use of medications in the veteran population. Her focus has been on assessing new agents where safety data is lacking (postmarketing surveillance) and older drugs when a newly emerging danger requires evaluation. Dr. Cunningham designed the VAMedSAFE and PBM Drug Safety Quality Improvement (QI) program. Under her direction the program has become a comprehensive pharmacovigilance program and a major tool in the evaluation of drug safety in the VA and its role in the formulary decision process. Since her time in the Department of Veterans Affairs, Dr. Cunningham has focused her research efforts in the area of drug safety. Dr. Cunningham's group has worked independently and with other researchers to perform several drug safety and pharmacoepidemiologic studies. She sits on several internal and external Boards and committees that focus on patient safety with an emphasis on pharmacovigilance and postmarketing surveillance including the newly formed government committee for the Sentinel Initiative.

William Fitzsimmons

William Fitzsimmons, BS '83
Executive Vice President, Global Regulatory Affairs
Global Clinical and Research Quality Assurance
Astellas Pharma Global Development, Inc.

Bill currently serves as Divisional Executive Vice President, Global Regulatory Affairs, Global Clinical and Research Quality at Astellas Pharma Global Development, Inc. He previously served as EVP of Regulatory, Drug Safety and Pharmacovigilance. Previous roles include senior vice president and vice president of business development. Prior to the merger forming Astellas in 2005, he was with Fujisawa Healthcare for 15 years. He also currently serves on the Executive Committee of the Board of Directors for the Illinois Biotechnology Industry Organization (iBIO).

After obtaining his bachelor's in pharmacy from the UIC College of Pharmacy in 1983, Bill went on to obtain a master's degree in Clinical Research Design and Statistical Analysis from the University of Michigan. He then obtained his PharmD from Virginia Commonwealth University.

Michael Flavin

Michael Flavin, PhD '83
Managing Director, Flavin Ventures LLC

Michael T. Flavin, chief executive officer and chairman, founded Advanced Life Sciences, Inc. in 1999. Prior to this date, he was the founder, chief executive officer and chairman of MediChem Life Sciences, Inc., a drug discovery technology and services company. Dr. Flavin took MediChem from start-up in 1987 through many stages of development including the completion of MediChem's private placement, the acquisition and integration of the ThermoGen and Emerald Biostructures as MediChem subsidiaries and MediChem's initial public offering October 2000. MediChem, as a subsidiary of deCODE, through May 2002. Dr. Flavin received a bachelor of science degree in Chemistry from the University of Notre Dame, a PhD in Medicinal Chemistry from the University of Illinois at Chicago and he completed a postdoctoral fellowship at Harvard University. Dr. Flavin is an adjunct professor for the department of medicinal chemistry and pharmacognosy at UIC College of Pharmacy. He was featured on the cover of the UIC Alumni magazine's May/June 2006 issue and is a past recipient of the Sister Margaret Wright Graduate Award. Dr. Flavin is the brother of John L. Flavin and Patrick W. Flavin.

David Hicks

David Hicks, RPh, ’76, MBA
Vice President, Pharmacy and Laboratory Services
University of Chicago Medical Center

David is a Pharmacy administrator/consultant with twenty-five years' experience in organizational leadership in healthcare and particular experience in change management and application of technologies. Prior to the University of Chicago, David worked as Director of Automation for McKesson Medication Management and was Administrative Director of Information Systems and Pharmacy at Rush-Copley Medical Center. David is a 1976 graduate of the UIC College of Pharmacy and holds and MBA from Keller Graduate School of Management.

Mike Maddux

Michael S. Maddux, PharmD, FCCP, RES ’80
Executive Director, American College of Clinical Pharmacy

Michael S. Maddux is Executive Director of the American College of Clinical Pharmacy. He received the Doctor of Pharmacy degree from the University of California, San Francisco, and completed residency training at the University of Illinois at Chicago. Dr. Maddux then joined the University of Illinois clinical pharmacy faculty where he developed and maintained a clinical practice and residency/fellowship training program in solid organ transplantation. In 1991, he moved to the St. Louis College of Pharmacy as Professor and Director of the Division of Pharmacy Practice, a post he held until joining the ACCP staff in October of 2003. Throughout his professional career Dr. Maddux was active in ACCP, serving as a member of the Board of Regents and as ACCP's first representative on the Board of Directors of the Council on Credentialing in Pharmacy. He chaired the ACCP Clinical Practice Affairs Subcommittee that authored ACCP's 2000 White Paper on pharmacy's future, and also served as chair of the writing group that developed the 2005 JCCP Future Vision of Pharmacy Practice. Mike lives in St. Louis, Missouri with his wife Susan and daughter Rachel.

Scott Meyers

Scott Meyers, BS '76, RPh, MS, FASHP
Executive Vice President, Illinois Council of Health-System Pharmacists

Scott is the Executive Vice President of the Illinois Council of Health-System Pharmacists, the Illinois affiliate of the American Society of Health-System Pharmacists. As the executive staff officer of ICHP, Scott is responsible for overseeing the day-to-day operations of the Council, acts as its continuing pharmaceutical education administrator for the Accreditiation Council for Pharmacy Education programs, and is a member of the Dean's Advisory Committee at the Midwestern University, Chicago State University of Colleges of Pharmacy and the Southern Illinois University at Edwardsville School of Pharmacy. He is Vice Chair and member of the Board of Governors of the Pharmacy Technician Certification Board, Inc. Scott is also a licensed lobbyist in the State of Illinois and serves as Treasurer of ICHP's Political Action Committee. In 2007 he was appointed to the newly established Commission on Continuing Pharmacy Education of the Accreditation Council for Pharmacy Education; he currently serves as the Commission's Chair. Prior to and during his early time with ICHP, Scott worked for 22 years in health-system pharmacy with additional experience in community and home care pharmacy practice. Scott received his BS in Pharmacy from the University of Illinois at Chicago. He received a Master of Science in Health Service Administration from St. Francis University in Joliet, IL. In 2004, Scott became a Fellow of the American Society of Health-System Pharmacists. In addition, Scott serves on the Board of Directors of the University of Illinois at Chicago College of Pharmacy Alumni Association.

Sarfaraz

Sarfaraz "Sarf" K. Niazi, PhD '74
CEO and Chairman – Therapeutic Proteins International

Dr. Niazi is the founder of Therapeutic Proteins International, LLC, a world class developer and manufacturer of lifesaving biological drugs; the vision at TPI is to make drugs affordable to all and this dream is being fulfilled by a team of world's most accomplished scientists, industry leaders, who all-share Sarf’s vision and passion. Published 100+ scholarly papers, owns 40+ patents, delivered 1000+ talks on scientific and literary topics, written over 40+ technical and literary books. His textbooks are required reading worldwide, and he generally allows their distribution royalty-free in developing countries, to let companies and governments in the developing countries manufacture safe and effective drugs and vaccines at an affordable cost using his formulations and technologies. He also teaches scientists in the developing countries on creating value through intellectual property and, in this capacity, serve an advisor to the Government of Pakistan.

Mark Pilkington

Mark Pilkington, BS '84, MS '88 (Chair)
Vice President Managed Care Product Strategies
Cardinal Health Inc.

Between 1990 and 1997, Pilkington served as executive director of the Illinois Pharmacists Association. He was the director of pharmacy affairs at Pharmacia Corporation, where he was responsible for building relationships with pharmacy professional groups from 1998 to 2003. He is the past president of the UIC Pharmacy Alumni Association Board of Directors and was voted Alumnus of the Year in 2003. He currently serves as the Sesquicentennial Development Subcommittee chair.

Anthony Provenzano

Anthony Provenzano, PharmD '92
Director of Clinical Programs, New Albertson’s Inc.

Dr. Provenzano is currently Director of Clinical Programs for New Albertson's Inc. Anthony graduated from University of Illinois College of Pharmacy in 1992. He began his career as a pharmacist at Osco Drug in Chicago. Shortly thereafter, he helped develop and grow their Diabetes Care Program. He has also developed and implemented numerous other clinical programs and services, including those that focus on the provision of medication therapy management services, wellness services and adult immunizations. Currently over 2300 pharmacists participate in his programs and provide services to hundreds of thousands of patients each year. He also oversees three community pharmacy residency programs with five current residents.

Anthony is a former Certified Diabetes Educator and a Fellow of the GlaxoSmithKline/Wharton Business School Executive Management Program for Pharmacy Leaders. He has served on numerous pharmacy association advisory panels and currently serves on the Pharmacy Quality Alliance, the National MTM Advisory Board for Outcomes Pharmaceutical Care, Inc., two Deans Advisory boards and the ACPE Board of Directors. He is also the 2003 recipient of the APhA/APPM Distinguished Service Award in Administrative Practice.

Ahnal Purohit

Ahnal Purohit, PhD (Former Faculty)
President & CEO – Purohit Navigation

Ahnal Purohit received her Ph.D. in psychometrics at the University of Delaware and settled in Illinois where she spent seven years as a professor at the University of Illinois, College of Pharmacy, teaching research methodology, statistics and pharmacy administration. In 1982, she gave up her tenure at the university and transitioned naturally into healthcare marketing, ultimately becoming vice president of market research for a major company. It was here she found that the deeper she delved into marketing, the more apparent it became that her scientific prowess provided a solid basis for her intuitive and creative insights. Ahnal's innovative spirit is what led her to leave and take her next big step: cofounding the company now known as Purohit Navigation, one of the largest independent healthcare communications companies led by a minority woman.

While Ahnal blazes distinct paths for each of her clients' brands, she manages to remain grounded by supporting many charitable, humanitarian, and environmental causes. She is the recipient of many industry and organizational awards, including being named one of PharmaVOICE's 100 Most Inspiring People in the Life Sciences Industry.

Densie Scarpelli

Denise Scarpelli, PharmD ‘96
Market Pharmacy Director, Walgreens

Dr. Denise Scarpelli received her doctorate in pharmacy from the college in 1996, and she is currently working for Walgreens as the market pharmacy director for the Chicago area. Denise has been employed by Walgreens for over 20 years serving in various roles from Pharmacy Manager to Pharmacy Supervisor. She has been a preceptor for many pharmacy schools over the years. Her current professional passion focuses on healthcare reform, and she is currently partnering with many health institutions to collaborate on how pharmacists can be more involved in the coordination of care. Denise oversees the Pharmacy Operations of stores within the Chicago land area and Northwest Indiana composing of 275 stores, with annual sales at $2.1 billion. The main responsibilities include sales, people management, strategic partnerships, and expense control. Another key area is partnering with other healthcare companies within the Chicagoland area to work on care coordination and healthcare reform projects.
She has 21 Pharmacies on medical campuses within the market.  Denise has also spent a large part of her career helping nonprofits with support from pharmacists; organizations such as the American Diabetes Association, American Heart Association, and the Chicago AIDS Foundation. She is currently an active member of the American College of Healthcare Executives and the Illinois Pharmacist Association.

Russell Secter

Russell Secter, BS '78
CEO, PDx BioTech

Secter has over 22 years of sales and marketing/business experience in the pharmaceutical industry, spanning traditional medical markets, generic pharmaceutical markets, dental pharmaceutical markets, and biopharmaceutical company start up. He was President of OraPharma for 10 years, five of which as president. Prior to that, Secter was the Executive Director of the Oncology Franchise at Searle Pharmaceuticals and held a variety of commercial roles at Novartis/Ciba Geigy. Secter Earned a Master's degree in Business Administration from Northwestern University-J.L. Kellogg School of Management, a PharmD from the University of Missouri-Kansas City School of Pharmacy, and a Bachelor's degree in Pharmacy from the University of Illinois at Chicago. He currently serves on the Board of Directors of PerioSciences and on the Advisory Board of BioFilm Technologies.

Russell Teagarden

Russell Teagarden, BS '78
Senior Vice President of Medical and Scientific Affairs
National Organization of Rare Disorders(NORD)

J. Russell Teagarden currently serves as Senior Vice President of Medical & Scientific Affairs at the National Organization for Rare Disorders (NORD). His primary roles mostly concern research and registry initiatives, clinical intelligence and support functions, education and publication programming, strategic alliance development, and idea generation. He joined NORD after 19 years at Medco Health Solutions where he was chiefly involved in drug technology assessment, coverage policy development, clinical programming development, clinical oversight, and clinical support for the company's clients and internal departments. He also held leadership roles there for company research initiatives. Prior to joining Medco, he practiced as a clinical pharmacist in critical care and drug information in the Chicago teaching hospital community.

Teagarden has a Bachelor of Science degree in Pharmacy from the University of Illinois College of Pharmacy, a Master of Arts degree in research methodology from Loyola University of Chicago, and a Doctor of Medical Humanities degree from Drew University. He completed a residency in hospital pharmacy at Northwestern University Medical Center and was visiting scholar at the National Institutes of Health Bioethics Department. He has served as a trustee of the Institute for Safe Medication Practices and the P&T Society. He currently serves on the Patient Centered Outcomes Research Institute (PCORI) Advisory Panel on Rare Disease, Oversight Body of the American Medical Association Ethical Force Program, the National Advisory Panel of the California Health Benefits Review Program, and the Therapeutic Information and Formulary Support Expert Committee of the United States Pharmacopeial Convention (USP). Teagarden has also held faculty appointments at several pharmacy schools and has served on deans' advisory councils. He publishes and speaks frequently on topics including clinical research, pharmacy, health policy, ethics, education, and the humanities.

Tom Temple

Tom Temple, BS '75
President, Temple Consulting
Director, Strategic Communications at University of Iowa

Tom was been with IPA for more than 30 years. As EVP and CEO, he is responsible for staff development and management, strategic planning with IPA Board of Trustees, business development, government relations programming, liaison with national pharmacy organizations and CEO of the Iowa Pharmacy Foundation. Tom received UIC Alumnus of the Year in 1998 and currently serves as co-head of the Sesquicentennial Steering Committee. 

Claire Thom

Claire Thom, BS '75, PharmD ‘82
Therapeutic Area Head – Oncology
Astellas Pharmaceuticals

Claire Thom has recently joined Astellas in the role of Therapeutic Area Head for Oncology. Prior to Astellas Claire spent 12years with Takeda. Her last position was Senior Vice President, Portfolio Management, Drug Development Management and Medical Informatics and Strategic Operations within the Medical Division (the Division within Millennium responsible for oncology clinical drug development within Takeda). During her four years at Millennium, at various times, she had responsibility within the Medical Division for leading portfolio management, business operations (medical finance, annual and mid-range financial planning, space planning and operations, headcount resourcing, development goals process), clinical development operations (clinical operations, programming, data management, statistics, medical writing, clinical outsourcing), drug development management (project management), medical informatics (technology support for the division) and the strategic project management office for the division. Prior to joining Millennium, Claire spent 18months working in Osaka, Japan during which time she was responsible for developing the oncology strategy for Takeda that culminated in the acquisition of Millennium. Before going to Japan, Claire held positions of varying responsibility within the Takeda US development organization including the management of regulatory affairs, safety, biometrics and data management, clinical research, and quality assurance. Claire has particular expertise in organizational design and efficiency; she has successfully worked through integrations across multiple functions and redesigned business processes. Claire has a PharmD from University of Illinois and over 20 years of pharmaceutical experience including positions in medical affairs and new product planning (over 11 years at Searle) and drug development (over 12 years at Takeda/Millennium).

Garry Zage

Garry Zage, R.Ph., BS ‘77
President & CEO – Kirby Lester, LLC

Garry Zage ('77) has over 35 years experience in the pharmacy industry, including more than 15 years in automation technology.  Zage is the only CEO of a pharmacy automation company who is also a pharmacist.

Prior to purchaing Kirby Lester, Zage co-founded and spent 10 years running a private consulting and development firm that advised and developed strategies with new healthcare start-up businesses.  Zage also held several executive business development as well as corporate sales and marketing roles with Baxter International prior to starting the consulting firm.

Immediately after graduation in 1977, Zage worked as a pharmacist at Loyola University Medical Center in Maywood, IL.  Zage also was in hospital pharmacy management and was promoted to a hostpital administrator over professional services (including pharmacy) at St. Joseph Hospital in Chicago.

Zage served as President of the Illinois Council of Health -System Pharmacists and sat on the Board of Directors of the Illinois Pharmacists Association.  In 1984, Zage was recognized for outstanding leadership by a young pharmacist when he received the Edmond P. Barcus Memorial Leadership Award from the Illinois Pharmacist's Association.  He currently serves on the Board of Directors for the Epilepsy Services of Northeastern Illinois and is a member the University of Illinois College of Pharmacy Advisory Board. In 2012, he received the Alumnus of the Year Award from the UIC College of Pharmacy.